61076-89-9 Usage
Uses
Given the limited information on the specific applications of 1-Methyl-2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide, the following uses are inferred based on its chemical structure and properties:
Used in Pharmaceutical Research:
1-Methyl-2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide is used as a research compound for exploring its potential pharmaceutical applications. Its unique structure and functional groups may offer novel therapeutic properties, which are yet to be fully understood and developed.
Used in Chemical Synthesis:
In the chemical industry, 1-Methyl-2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide may serve as an intermediate or a building block in the synthesis of more complex organic compounds, including pharmaceuticals, agrochemicals, or other specialty chemicals.
Used in Analytical Chemistry:
Due to its unique structure and properties, 1-Methyl-2-(methylthio)-4,5-dihydro-1H-imidazole hydroiodide could be employed as a reagent or a standard in analytical chemistry for the development of new methods or the calibration of analytical instruments.
Check Digit Verification of cas no
The CAS Registry Mumber 61076-89-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,0,7 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 61076-89:
(7*6)+(6*1)+(5*0)+(4*7)+(3*6)+(2*8)+(1*9)=119
119 % 10 = 9
So 61076-89-9 is a valid CAS Registry Number.
InChI:InChI=1/C5H10N2S.HI/c1-7-4-3-6-5(7)8-2;/h3-4H2,1-2H3;1H
61076-89-9Relevant academic research and scientific papers
HEPATITIS C VIRUS INHIBITORS
-
Page/Page column 223, (2009/10/09)
The present disclosure relates to (4-4' -diimidazolyl) biphenyls compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
-
Page/Page column 137, (2008/06/13)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Hepatitis C Virus Inhibitors
-
Page/Page column 135-136, (2008/06/13)
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
